As shown in Figure 4E, the high‐AD BM‐MSCs group (with low expression of GREM1) significantly reduced the survival rate of the animals (p = 0.0365), providing in vivo evidence supporting the role of GREM1 deficiency derived from BM‐MSCs in the progression of ALL. Here, GREM1 is linked to acute lymphoblastic leukemia.